UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 80

of 'Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects'

80
TI
What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?
AU
Han ES, Monk BJ
SO
Gynecol Oncol. 2007;105(1):3.
 
AD
PMID